Archives

Hep-C Outcomes 2023 216 115 Shields Health Solutions

Hep-C Outcomes 2023

Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) and is spread through contact with the blood of an infected person.

RA Outcomes 2023 216 115 Shields Health Solutions

RA Outcomes 2023

RA is an autoimmune and inflammatory disease where the immune system attacks healthy cells, causing inflammation and painful swelling in the affected parts of the body.

MS Outcomes 2023 216 115 Shields Health Solutions

MS Outcomes 2023

MS is a chronic, autoimmune disease of the central nervous system, affecting the communication between the brain and other parts of the body

Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Clinical Outcomes in Cystic Fibrosis Patients Enrolled in an Integrated Health System Specialty Pharmacy Care Model

This poster presents an evaluation of outcomes in cystic fibrosis (CF) patients within a health system specialty pharmacy care model by comparing them to established benchmarks.      

Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy 216 115 Shields Health Solutions

Clinical Outcomes of Migraine Patients Receiving Calcitonin Gene-Related Peptide Antagonists from an Integrated Health System Specialty Pharmacy

This poster evaluates the percent reduction in patient-reported monthly migraine days of patients receiving CGRPs from an integrated health system specialty pharmacy (HSSP).      

Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes 216 115 Shields Health Solutions

Impact of Integrated Health System Specialty Pharmacy Services on Inflammatory Bowel Disease Outcomes

This poster presents an assessment of how health system specialty pharmacy (HSSP) services can improve clinical outcomes for IBD patients.    

Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Process 216 115 Shields Health Solutions

Evaluation of a Social Determinants of Health Screening and Intervention Framework within an Integrated Health System Specialty Pharmacy Care Model Using a Closed-Loop Referral Process

This poster presents an evaluation of a social determinants of health screening and intervention framework within an integrated health system specialty pharmacy care modelĀ using a closed-loop referral process.    

Evaluation of a Social Determinants of Health Screening and Intervention Framework Within an Integrated Health System Specialty Pharmacy Care Model 216 115 Shields Health Solutions

Evaluation of a Social Determinants of Health Screening and Intervention Framework Within an Integrated Health System Specialty Pharmacy Care Model

This poster evaluates the critical role of health system specialty pharmacies in addressing social determinants of health (SDOH) barriers through tailored interventions.      

Implementation of an Ambulatory Clinical Pharmacist-Led Obesity Care Program Within an Integrated Health-System Specialty Pharmacy 216 115 Shields Health Solutions

Implementation of an Ambulatory Clinical Pharmacist-Led Obesity Care Program Within an Integrated Health-System Specialty Pharmacy

This poster describes the impact of implementing ambulatory clinical pharmacist (ACP)-led medication management services specializing in diabetes care within an integrated HSSP.  

Development and Implementation of Real-Time Dashboards for Specialty Pharmacy Clinical Outcome Measures 216 115 Shields Health Solutions

Development and Implementation of Real-Time Dashboards for Specialty Pharmacy Clinical Outcome Measures

This poster highlights how the implementation of clinical outcome dashboards helps improve quality of care, patient satisfaction, and overall organizational performance and capabilities in health system specialty pharmacies.